- Dairy food intake
- Cognitive functioning
- Methodological review
Background: Diet is a modifiable factor that could be targeted as an appropriate intervention to optimise cognitive health and well-being in ageing. Aim: The aim of this systematic review was to consider current evidence for an association between dairy intake and cognitive functioning. Methods: Searches of the electronic databases Medline, Embase, Web of Science, CINAHL, and PsychInfo were undertaken to identify peer-reviewed journal articles that reported on associations between dairy consumption and cognitive outcomes. Results: Three cross-sectional and 5 prospective studies were identified. Poorer cognitive function and an increased risk for vascular dementia were found to be associated with a lower consumption of milk or dairy products. However, the consumption of whole-fat dairy products may be associated with cognitive decline in the elderly. Conclusion: Methodological variability and study limitations do not enable conclusions regarding optimal dairy intake and cognitive performance to be drawn. Randomised controlled trials are needed to confirm the relationship between dairy intake and cognition.
Copyright © 2010 S. Karger AG, Basel
- United Nations: World Population Ageing 1950–2050. New York, United Nations, 2001.
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.
- Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M: Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112–2117.
- Bryan J: Mechanisms and evidence for the role of nutrition in cognitive ageing. Ageing Int 2004;29:28–45.
- Solfrizzi V, Panza F, Capurso A: The role of diet in cognitive decline. J Neural Transm 2003;110:95–110.
- Tooth L, Ware R, Bain C, Purdie DM, Dobson A: Quality of reporting of observational longitudinal research. Am J Epidemiol 2005;161:280–288.
- Hayden JA, Cote P, Bombardier C: Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427–437.
- Eskelinen MH, Ngandu T, Helkala EL, Tuomilehto J, Nissinen A, Soininen H, Kivipelto M: Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int J Geriatr Psychiatry 2008;23:741–747.
- Laitinen MH, Ngandu T, Rovio S, Helkala EL, Uusitalo U, Viitanen M, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M: Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study. Dement Geriatr Cogn Disord 2006;22:99–107.
- Avila-Funes JA, Garant MP, Aguilar-Navarro S: Relationship between determining factors for depressive symptoms and for dietary habits in older adults in Mexico. Rev Panam Salud Publica 2006;19:321–330.
- Lee L, Kang SA, Lee HO, Lee BH, Park JS, Kim JH, Jung IK, Park YJ, Lee JE: Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health 2001;115:133–138.
- Rahman A, Sawyer Baker P, Allman RM, Zamrini E: Dietary factors and cognitive impairment in community-dwelling elderly. J Nutr Health Aging 2007;11:49–54.
- Almeida OP, Norman P, Hankey G, Jamrozik K, Flicker L: Successful mental health aging: results from a longitudinal study of older Australian men. Am J Geriatr Psychiatry 2006;14:27–35.
- Vercambre MN, Boutron-Ruault MC, Ritchie K, Clavel-Chapelon F, Berr C: Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women. Br J Nutr 2009;102:419–427.
- Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G: Association between dementia and midlife risk factors: the radiation effects research foundation adult health study. J Am Geriatr Soc 2003;51:410–414.
- Cullen B, O’Neill B, Evans JJ, Coen RF, Lawlor BA: A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry 2007;78:790–799.
- Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR: Role of vascular risk factors and vascular dysfunction in Alzheimer’s disease. Mt Sinai J Med 2010;77:82–102.
- Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H: Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006;22:376–384.
- Soderlund H, Nilsson LG, Berger K, Breteler MM, Dufouil C, Fuhrer R, Giampaoli S, Hofman A, Pajak A, de Ridder M, Sans S, Schmidt R, Launer LJ: Cerebral changes on MRI and cognitive function: the cascade study. Neurobiol Aging 2006;27:16–23.
- Verdelho A, Madureira S, Ferro JM, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O’Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D, Study L: Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry 2007;78:1325–1330.
- Wright CB, Festa JR, Paik MC, Schmiedigen A, Brown TR, Yoshita M, DeCarli C, Sacco R, Stern Y: White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008;39:800–805.
- Rabbitt P, Mogapi O, Scott M, Thacker N, Lowe C, Horan M, Pendleton N, Jackson A, Lunn D: Effects of global atrophy, white matter lesions, and cerebral blood flow on age-related changes in speed, memory, intelligence, vocabulary, and frontal function. Neuropsychology 2007;21:684–695.
- Tiehuis AM, Vincken KL, van den Berg E, Hendrikse J, Manschot SM, Mali WP, Kappelle LJ, Biessels GJ: Cerebral perfusion in relation to cognitive function and type 2 diabetes. Diabetologia 2008;51:1321–1326.
- Breteler MM, van Amerongen NM, van Swieten JC, Claus JJ, Grobbee DE, van Gijn J, Hofman A, van Harskamp F: Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam study. Stroke 1994;25:1109–1115.
- van den Berg E, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ: Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta 2009;1792:470–481.
- Zemel MB: Role of calcium and dairy products in energy partitioning and weight management. Am J Clin Nutr 2004;79:907S–912S.
- Zemel MB, Teegarden D, Van Loan MD, Schoeller DA, Matkovic V, Lyle RM, Craig BA: Dairy-rich diets augment fat loss on an energy-restricted diet: a multicenter trial. Nutrients 2009;1:83–100.
- Teegarden D: The influence of dairy product consumption on body composition. J Nutr 2005;135:2749–2752.
- Zemel MB: The role of dairy foods in weight management. J Am Coll Nutr 2005;24:537S–546S.
- Luhovyy BL, Akhavan T, Anderson H: Whey proteins in the regulation of food intake and satiety. J Am Coll Nutr 2007;26:704S–712S.
- Teegarden D, Donkin SS: Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 2009;22:82–92.
- von Hurst PR, Stonehouse W, Coad J: Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr 2010;103:549–555.
- Alonso A, Nettleton JA, Ix JH, de Boer IH, Folsom AR, Bidulescu A, Kestenbaum BR, Chambless LE, Jacobs DR Jr: Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Hypertension 2010;55:776–784.
- Sontia B, Touyz RM: Role of magnesium in hypertension. Arch Biochem Biophys 2007;458:33–39.
- Weglicki WB, Mak IT, Kramer JH, Dickens BF, Cassidy MM, Stafford RE, Philips TM: Role of free radicals and substance p in magnesium deficiency. Cardiovasc Res 1996;31:677–682.
- Singh RB, Rastogi SS, Sharma VK, Saharia RB, Kulshretha SK: Can dietary magnesium modulate lipoprotein metabolism? Magnes Trace Elem 1990;9:255–264.
- Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ: Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 2006;164:449–458.
- Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A: Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294:1–26.
- Festa A, D’Agostino R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM: The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes 2001;25:1407–1415.
- Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G: C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes 2001;25:1416–1420.
- Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ: Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002;52:168–174.
- Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237–2242.
- Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T: Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61:76–80.
Nutritional Physiology Research Centre, University of South Australia
GPO Box 2471, Adelaide, SA 5001 (Australia)
Tel. +61 8 8302 1452, Fax +61 8 8302 2178
Accepted: August 27, 2010
Published online: October 12, 2010
Number of Print Pages : 10
Number of Figures : 0, Number of Tables : 4, Number of References : 43
Dementia and Geriatric Cognitive Disorders
Vol. 30, No. 4, Year 2010 (Cover Date: October 2010)
Journal Editor: Chan-Palay V. (New York, N.Y.)
ISSN: 1420-8008 (Print), eISSN: 1421-9824 (Online)
For additional information: http://www.karger.com/DEM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.